Title : Dapagliflozin Alleviates Renal Fibrosis by Inhibiting RIP1-RIP3-MLKL-Mediated Necroinflammation in Unilateral Ureteral Obstruction.

Pub. Date : 2021

PMID : 35069210






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Dapagliflozin Alleviates Renal Fibrosis by Inhibiting RIP1-RIP3-MLKL-Mediated Necroinflammation in Unilateral Ureteral Obstruction. dapagliflozin mixed lineage kinase domain like pseudokinase Rattus norvegicus
2 In H2O2-treated HK-2 cells, dapagliflozin and RIP inhibitors suppressed overexpression of RIP1-RIP3-MLKL proteins and pyroptosis-related cytokines, decreased intracellular reactive oxygen species production and apoptotic cell death, whereas cell viability was improved. dapagliflozin mixed lineage kinase domain like pseudokinase Rattus norvegicus
3 Our findings suggest that dapagliflozin ameliorates renal fibrosis by inhibiting RIP1-RIP3-MLKL-mediated necroinflammation via Wnt3alpha/beta-catenin/GSK-3beta signaling in UUO. dapagliflozin mixed lineage kinase domain like pseudokinase Rattus norvegicus